Trial Profile
Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacodynamics
- 25 Jun 2019 Status changed from active, no longer recruiting to discontinued.
- 04 Sep 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 04 Sep 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.